Geode Capital Management’s Aethlon Medical AEMD Stock Holding History

Geode Capital Management’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.39K	Sell	2,038 -2,835	-58%	-$29.4K	﹤0.01%	4430
2026 Q1	$53.4K	Buy	+4,873	New	+$55.4K	﹤0.01%	4294
2025 Q4	–	Sell	-269	Closed	-$10.1K	–	4473
2025 Q3	$10.1K	Hold	269	–	–	﹤0.01%	4446
2025 Q2	$16.2K	Sell	269 -42	-14%	-$5.63K	﹤0.01%	4386
2025 Q1	$44.5K	Buy	311 +35	+13%	+$8.15K	﹤0.01%	4222
2024 Q4	$94.9K	Buy	276 +30	+12%	+$5.09K	﹤0.01%	4108
2024 Q3	$45.9K	Buy	246 +195	+382%	+$31K	﹤0.01%	4277
2024 Q2	$10.1K	Hold	51	–	–	﹤0.01%	4546
2024 Q1	$34.1K	Hold	51	–	–	﹤0.01%	4397
2023 Q4	$44.4K	Hold	51	–	–	﹤0.01%	4377
2023 Q3	$42.8K	Buy	51 +9	+21%	+$11.6K	﹤0.01%	4455
2023 Q2	$61K	Hold	42	–	–	﹤0.01%	4461
2023 Q1	$65.2K	Hold	42	–	–	﹤0.01%	4457
2022 Q4	$46K	Hold	42	–	–	﹤0.01%	4607
2022 Q3	$98K	Hold	42	–	–	﹤0.01%	4584
2022 Q2	$190K	Buy	42 +1	+2%	+$4.66K	﹤0.01%	4297
2022 Q1	$240K	Hold	41	–	–	﹤0.01%	4287
2021 Q4	$306K	Buy	41 +7	+21%	+$79.7K	﹤0.01%	4285
2021 Q3	$526K	Buy	34 +8	+31%	+$134K	﹤0.01%	4009
2021 Q2	$507K	Buy	26 +9	+53%	+$104K	﹤0.01%	3938
2021 Q1	$135K	Hold	17	–	–	﹤0.01%	4228
2020 Q4	$164K	Buy	17 +13	+325%	+$86.9K	﹤0.01%	3937
2020 Q3	$23K	Hold	4	–	–	﹤0.01%	4112
2020 Q2	$35K	Buy	+4	New	+$24.2K	﹤0.01%	4029
2019 Q4	–	Sell	-2	Closed	-$29K	–	4208
2019 Q3	$29K	Hold	2	–	–	﹤0.01%	4113
2019 Q2	$46K	Hold	2	–	–	﹤0.01%	4088
2019 Q1	$120K	Buy	2 +1	+100%	+$70.8K	﹤0.01%	3854
2018 Q4	$102K	Hold	1	–	–	﹤0.01%	3852
2018 Q3	$73K	Hold	1	–	–	﹤0.01%	3978
2018 Q2	$79K	Buy	+1	New	+$78.4K	﹤0.01%	3916
2018 Q1	–	Hold	0	–	–	–	3998
2017 Q4	–	Hold	0	–	–	–	3982
2017 Q3	–	Hold	0	–	–	–	3967
2017 Q2	–	Hold	0	–	–	–	3955
2017 Q1	–	Hold	0	–	–	–	3870
2016 Q4	–	Hold	0	–	–	–	3791
2016 Q3	–	Hold	0	–	–	–	3763
2016 Q2	–	Hold	0	–	–	–	3704
2016 Q1	–	Hold	0	–	–	–	3751
2015 Q4	–	Hold	0	–	–	–	3747
2015 Q3	–	Hold	0	–	–	–	3729

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's AEMD Position: Q2 2026 in Review

Geode Capital Management reduced its Aethlon Medical (AEMD) stake by 58% in Q2 2026, selling an estimated $29.4K and leaving 2,038 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #4430.

Geode Capital Management first reported a position in AEMD in Q2 2018 and has held it in 30 quarters since. The position peaked at $526K in Q3 2021. 16 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

Geode Capital Management held 2,038 shares of Aethlon Medical worth $8.39K as of Q2 2026.
Geode Capital Management sold 2,835 Aethlon Medical shares in Q2 2026, an estimated $29.4K.
Aethlon Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4430 holding.
Geode Capital Management first reported a position in Aethlon Medical in Q2 2018 and has held it in 30 quarters since.
Geode Capital Management's Aethlon Medical position peaked at $526K in Q3 2021.
16 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.